BPC TB 5 Beverly Hills Rejuvenation Center FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Compounded "semaglutide" is not FDA approved semaglutide.com AP's BPC 157 peptide warning skips every doctor who disagrees Seattle Red The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York